Annual General Meeting 2017 in Karo Pharma AB (publ)
STOCKHOLM, Sweden, May 11, 2017 – At today’s Annual General Meeting in Karo Pharma the following main resolutions were passed. The AGM voted in favour of adopting the income statements and balance sheets for the Group and the parent company. The AGM decided that funds at the disposal of the general meeting, amounting to SEK 686 855 101, including the profit for the year amounting to SEK 74 611 722, should be disposed as follows: · A dividend per share of SEK 0,50, amounting to SEK 41 083 195,60 · To be carried forward, SEK 645 771 905,50 The AGM further discharged the Board